Brand Identity & Mission

Adding gentle protection to your pet’s cancer-fighting journey

Gongwin Pet Biomedicine believes that pets are not just animals – they are family.
We are committed to developing innovative therapies that combine image-guided precision and next-generation drug design, so treatments can focus more on the tumor itself while reducing the burden on pets as much as possible.

Our core mission is to accompany pets and their families through the fight against disease in a safer and more comforting way.

Our Story

Why did we enter this field?

It all started from a simple belief: pets, just like humans, deserve better medical care.
While human medicine has made progress in cancer treatment, we saw that veterinary options were still limited. Many pets suffer from side effects and pain during treatment, which made us realize that a different path is needed.

So we applied experience from human medicine and focused on developing precise, pet-friendly treatments to narrow the gap between human and veterinary oncology.
We believe cancer treatment should not be only about extending life, but also about helping pets maintain quality of life and joy in every day they spend with their families.

This is not only medical R&D — it is our promise to protect pets and the families who love them.

New Hope for Pet Treatment

R&D and Progress

Gongwin Pet Biomedicine is dedicated to developing innovative tumor therapies. After years of effort, we have completed preclinical and field trials and presented our results at international conferences. The studies showed significant local changes in tumors after treatment, with an overall favorable safety profile.

Our product is currently under drug permit review. Once approval is granted, it will be officially launched as a new option for pets facing cancer. In the future, we will continue working with clinical veterinarians to expand applications and collect more clinical data, so we can bring even more protection to pets and their owners.

Pet Health Education